RBC Capital lowered the firm’s price target on GoHealth (GOCO) to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following the company’s Q3 results, which came in significantly below expectations due to topline weakness as a result of one large carrier suspending its relationship with, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOCO:
- William Blair downgrades GoHealth, says market headwinds likely to persist
- GoHealth downgraded to Market Perform from Outperform at William Blair
- GoHealth files to sell 4.77M shares of Class A common stock for holders
- GoHealth price target lowered to $10 from $20 at Noble Capital
- GoHealth, Inc. Reports Strategic Shift Amid Market Changes